5Cardillo JA, Stout T, LaBree L, et al. Post-traumatic proliferative vitreoretinopathy. The epidemiologic profile,onset, rlsk factors, and visual outcome [J]. Ophthalmology, 1997, 104 (7):1166-1173.
6Tano Y, Chandler D, Machemer R, et al. Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide[J]. Am J Ophthalmol, 1980,90(6) :810-816.
7Enaida H, Hata Y. Possible benefits of triamcinolone-assisted pars plana vitretomy for retinal diseases[J]. Retina, 2003,23 (6): 764-770.
8Sakamoto T,Miyazaki M, Hisatomi T, et al. Triamcinolone- assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown[J]. Graefes Arch Clin Exp Ophthalmol,2002,240 (6) :423-429.
9Fastemberg DM, Diddie KR, Sorgente N,et al. A eomparison of different cellular inocula in an experimental, modelof massive periretinal proliferation[J]. Am J Ophthalmol, 1982, 93(5) : 559-572.
10ArchJohnson RN, Olsen KR, Hernandez E. Intravitreal tissue plasminogen activator treatment of experimental vitreous hemorrhage[J].Arch Ophthalmol, 1989,107(7) : 891-894.
